Depreciation of Xtant Medical Holdings, Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Xtant Medical Holdings, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • Xtant Medical Holdings, Inc. Depreciation for the quarter ending 30 Sep 2025 was $700,000, unchanged year-over-year.
  • Xtant Medical Holdings, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $2,800,000, a 17% increase year-over-year.
  • Xtant Medical Holdings, Inc. annual Depreciation for 2024 was $2,500,000, a 39% increase from 2023.
  • Xtant Medical Holdings, Inc. annual Depreciation for 2023 was $1,800,000, a 50% increase from 2022.
  • Xtant Medical Holdings, Inc. annual Depreciation for 2022 was $1,200,000, a 7.7% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Xtant Medical Holdings, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,800,000 $700,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $2,800,000 $800,000 +$300,000 +60% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $2,500,000 $600,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $2,500,000 $700,000 +$100,000 +17% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q3 2024 $2,400,000 $700,000 +$200,000 +40% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $2,200,000 $500,000 +$100,000 +25% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $2,100,000 $600,000 +$300,000 +100% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $1,800,000 $600,000 +$400,000 +200% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $1,400,000 $500,000 +$100,000 +25% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,300,000 $400,000 +$100,000 +33% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $1,200,000 $300,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $1,200,000 $200,000 -$100,000 -33% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $1,300,000 $400,000 +$100,000 +33% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $1,200,000 $300,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $1,200,000 $300,000 -$100,000 -25% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $1,300,000 $300,000 -$100,000 -25% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $1,400,000 $300,000 -$200,000 -40% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $1,600,000 $300,000 -$100,000 -25% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $1,700,000 $400,000 -$300,000 -43% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $2,000,000 $400,000 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $500,000 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $400,000 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $700,000 -$100,000 -12% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q1 2019 $800,000 +$100,000 +14% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $700,000 -$210,465 -23% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $910,465 +$252,289 +38% 01 Jan 2017 31 Mar 2017 10-Q 30 Mar 2018 2017 Q1
Q1 2016 $658,176 +$492,773 +298% 01 Jan 2016 31 Mar 2016 10-Q 30 Mar 2018 2017 Q1
Q1 2015 $165,403 +$15,171 +10% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q1 2014 $150,232 -$31,229 -17% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q1 2013 $181,461 -$13,291 -6.8% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $194,752 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q2 2011 $157,019 +$5,358 +3.5% 01 Apr 2011 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q2 2010 $151,661 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2

Xtant Medical Holdings, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,500,000 +$700,000 +39% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $1,800,000 +$600,000 +50% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $1,200,000 -$100,000 -7.7% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $1,300,000 -$700,000 -35% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 $2,000,000 -$1,100,000 -35% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $3,100,000 -$100,000 -3.1% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2021 2020 FY
2018 $3,200,000 -$600,000 -16% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $3,800,000 +$1,368,381 +56% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $2,431,619 +$1,755,079 +259% 01 Jan 2016 31 Dec 2016 10-K 05 Apr 2018 2017 FY
2015 $676,540 +$105,814 +19% 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2017 2016 FY
2014 $570,726 -$107,130 -16% 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2016 2015 FY
2013 $677,856 -$30,115 -4.3% 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2015 2014 FY
2012 $707,971 +$6,223 +0.89% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014 2013 FY
2011 $701,748 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.